Dimensional Fund Advisors LP Acquires 180,348 Shares of Perrigo Company (PRGO)

Dimensional Fund Advisors LP raised its holdings in Perrigo Company (NYSE:PRGO) by 40.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 622,690 shares of the company’s stock after buying an additional 180,348 shares during the period. Dimensional Fund Advisors LP owned approximately 0.44% of Perrigo worth $52,699,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. State of Tennessee Treasury Department raised its holdings in shares of Perrigo by 0.3% in the 2nd quarter. State of Tennessee Treasury Department now owns 39,214 shares of the company’s stock valued at $2,961,000 after purchasing an additional 103 shares in the last quarter. Sentry Investment Management LLC raised its holdings in shares of Perrigo by 1.1% in the 2nd quarter. Sentry Investment Management LLC now owns 11,028 shares of the company’s stock valued at $833,000 after purchasing an additional 117 shares in the last quarter. Commonwealth Bank of Australia raised its holdings in shares of Perrigo by 13.8% in the 2nd quarter. Commonwealth Bank of Australia now owns 1,455 shares of the company’s stock valued at $108,000 after purchasing an additional 176 shares in the last quarter. Nationwide Fund Advisors raised its holdings in shares of Perrigo by 0.4% in the 2nd quarter. Nationwide Fund Advisors now owns 55,199 shares of the company’s stock valued at $4,169,000 after purchasing an additional 200 shares in the last quarter. Finally, Bank of Nova Scotia raised its holdings in shares of Perrigo by 7.8% in the 2nd quarter. Bank of Nova Scotia now owns 3,469 shares of the company’s stock valued at $262,000 after purchasing an additional 250 shares in the last quarter. 83.29% of the stock is owned by institutional investors.

A number of equities research analysts have recently weighed in on PRGO shares. Oppenheimer began coverage on shares of Perrigo in a report on Thursday, September 7th. They issued an “outperform” rating and a $88.00 price objective on the stock. CIBC began coverage on shares of Perrigo in a research note on Thursday, September 7th. They set an “outperform” rating and a $88.00 price target on the stock. BidaskClub upgraded shares of Perrigo from a “strong sell” rating to a “sell” rating in a research note on Saturday, September 9th. Cantor Fitzgerald lifted their price target on shares of Perrigo from $93.00 to $107.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 12th. Finally, Canaccord Genuity reiterated a “buy” rating and set a $100.00 price target (up from $88.00) on shares of Perrigo in a research note on Wednesday, September 13th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and nine have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $92.00.

Perrigo Company (NYSE:PRGO) opened at $91.08 on Friday. The company has a quick ratio of 1.24, a current ratio of 1.72 and a debt-to-equity ratio of 0.54. The company has a market cap of $12,596.79, a price-to-earnings ratio of 18.25, a price-to-earnings-growth ratio of 1.73 and a beta of 0.70. Perrigo Company has a one year low of $63.68 and a one year high of $92.04.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Thursday, November 9th. The company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.28. The company had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.17 billion. Perrigo had a negative net margin of 26.28% and a positive return on equity of 11.60%. Perrigo’s quarterly revenue was down 2.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.65 earnings per share. equities research analysts anticipate that Perrigo Company will post 4.88 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 19th. Shareholders of record on Friday, December 1st were paid a $0.16 dividend. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $0.64 dividend on an annualized basis and a yield of 0.70%. Perrigo’s dividend payout ratio is presently -6.99%.

In other Perrigo news, VP Todd W. Kingma sold 1,500 shares of Perrigo stock in a transaction on Thursday, December 28th. The shares were sold at an average price of $88.52, for a total value of $132,780.00. Following the transaction, the vice president now directly owns 19,565 shares in the company, valued at $1,731,893.80. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP John Wesolowski sold 388 shares of Perrigo stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $87.20, for a total transaction of $33,833.60. Following the completion of the transaction, the executive vice president now owns 248 shares in the company, valued at $21,625.60. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,051 shares of company stock worth $355,370. 6.90% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.chaffeybreeze.com/2018/01/05/dimensional-fund-advisors-lp-acquires-180348-shares-of-perrigo-company-prgo.html.

Perrigo Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company (NYSE:PRGO).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply